A paper detailing the clinical trial of a physician-initiated clinical study using injectable cell scaffold (ICS-001) for comprehensive angiogenesis therapy for severe chronic lower limb ischemia (...

A paper detailing the details of a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemia (CLTI) angiogenesis therapy using Injectable cell scaffold (ICS-001), led by CEO Kenichi Yamahara, has been published in BMJ Open.

This clinical trial has now completed enrollment for all planned cases and is scheduled to conclude in July of next year. The trial results are expected to be released in the latter half of next year.

https://bmjopen.bmj.com/content/15/10/e107486.full